ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Research and development (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $3.2B | +8.9% | 4.0% | 7.7% |
| Research and development (TTM) | $3.2B |
|---|---|
| YoY | +8.9% |
| 5-year CAGR | 4.0% |
| 10-year CAGR | 7.7% |
Research and development
| Period | R&D | YoY |
|---|---|---|
| 2025 | $2.9B | +3.4% |
| 2024 | $2.8B | +3.8% |
| 2023 | $2.7B | −5.1% |
| 2022 | $2.9B | +5.3% |
| 2021 | $2.7B | +13.3% |
| 2020 | $2.4B | −0.8% |
| 2019 | $2.4B | +6.1% |
| 2018 | $2.3B | +1.8% |
| 2017 | $2.3B | +56.2% |
| 2016 | $1.4B | +3.0% |
| 2015 | $1.4B | +4.5% |
| 2014 | $1.3B | −1.9% |
| 2013 | $1.4B | −6.2% |
| 2012 | $1.5B | −3.4% |
| 2011 | $1.5B | −59.4% |
| 2010 | $3.7B | +35.7% |
| 2009 | $2.7B | +2.0% |
| 2008 | $2.7B | +7.3% |
| 2007 | $2.5B | — |